Hepatic safety of buprenorphine in HIV-infected and uninfected patients with opioid use disorder: The role of HCV-infection

INTRODUCTION: Individuals with HIV and hepatitis C (HCV) infection, alcohol use disorder, or who are prescribed potentially hepatotoxic medications may be at increased risk for buprenorphine (BUP) associated hepatotoxicity. MATERIALS AND METHODS: We examined a cohort of HIV-infected and uninfected p...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Subst Abuse Treat
Auteurs principaux: Tetrault, Jeanette M., Tate, Janet P., Edelman, E. Jennifer, Gordon, Adam J., Re, Vincent Lo, Lim, Joseph K., Rimland, David, Goulet, Joseph, Crystal, Stephen, Gaither, Julie R., Gibert, Cynthia L., Rodriguez-Barradas, Maria C., Fiellin, Lynn E., Bryant, Kendall, Justice, Amy C., Fiellin, David A.
Format: Artigo
Langue:Inglês
Publié: 2016
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4976086/
https://ncbi.nlm.nih.gov/pubmed/27431048
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jsat.2016.06.002
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires